https://orcid.org/0000-0001-7082-4601
References
- Greenland P, Knoll MD, Stamler J, et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA. 2003;290(7):891–897. doi:10.1001/jama.290.7.891
- Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998;339(4):229–234. doi:10.1056/NEJM199807233390404
- Awad SF, Huangfu P, Dargham SR, et al. Characterizing the type 2 diabetes mellitus epidemic in Jordan up to 2050. Sci Rep. 2020;10(1):21001. doi:10.1038/s41598-020-77970-7
- Ajlouni K, Batieha A, Jaddou H, et al. Time trends in diabetes mellitus in Jordan between 1994 and 2017. Diabet Med. 2019;36(9):1176–1182. doi:10.1111/dme.13894
- Tuomilehto J, Lindström J, Eriksson JG, et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–1350. doi:10.1056/NEJM200105033441801
- American Diabetes Association (ADA) Risk Calculator. American Diabetes Association (ADA) risk calculator [Internet]; [cited February 3, 2021]. Available from: https://www.mdcalc.com/american-diabetes-association-ada-risk-calculator. Accessed July 23, 2021.
- Public Health Agency of Canada. The Canadian diabetes risk questionnaire: CANRISK.
- FINDRISC. FINDRISC (Finnish diabetes risk score) [Internet]; [cited February 3, 2021]. Available from: https://www.mdcalc.com/findrisc-finnish-diabetes-risk-score?__cf_chl_captcha_tk__=7292cf59fe8b5f1408a3e2633ec37dc8f1c06a88-1614700160-0-ATMOyUsKgOuS7-J2y6nqQBftW7u-307PqbgqXiESz8vSTnboWogYesWmJLG7o3Y0Ll43k43ymFGlAreWhw15n-Xa4y-zU3Ukb7k26FRArBi4uLxBC1SRY44. Accessed July 23, 2021.
- Diabetes UK. Diabetes UK score system [Internet]; [cited February 3, 2021]. Available from: https://riskscore.diabetes.org.uk/start. Accessed July 23, 2021.
- Mühlenbruch K, Ludwig T, Jeppesen C, et al. Update of the German diabetes risk score and external validation in the German MONICA/KORA study. Diabetes Res Clin Pract. 2014;104(3):459–466. doi:10.1016/j.diabres.2014.03.013
- The Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK). Australian government department of health [Internet]; [cited April 18, 2021]. Available from: https://www.health.gov.au/resources/apps-and-tools/the-australian-type-2-diabetes-risk-assessment-tool-ausdrisk
- Al-Shudifat A-E, Al-Shdaifat A, Al-Abdouh AA, et al. Diabetes risk score in a young student population in Jordan: a cross-sectional study. J Diabetes Res. 2017;2017:1–5. doi:10.1155/2017/8290710
- Pan X-R, Li G, Hu Y-H, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–544. doi:10.2337/diacare.20.4.537
- Group DPPR. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015;3(11):866–875. doi:10.1016/S2213-8587(15)00291-0
- Knowler WC, Barrett-Connor E, Fowler SF, et al. Diabetes Prevention Program Research Group Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.
- Hartmann-Boyce J, Morris E, Goyder C, et al. Diabetes and COVID-19: risks, management, and learnings from other national disasters. Diabetes Care. 2020;43(8):1695–1703. doi:10.2337/dc20-1192